Austin, TX -- (SBWIRE) -- 05/07/2013 -- Jackpotpennystocks.com, an investor research portal specializing in several sectors including biotech and healthcare and tech stocks on the U.S. market, issues news updates on the following stock:-
MBIA Inc. (NYSE:MBI) shares soared 45.37% to $14.29. The company on May 6 announced that it has, together with its subsidiaries MBIA Insurance Corporation (MBIA Corp.) and National Public Finance Guarantee Corporation (National), agreed to the terms of a comprehensive settlement agreement and related agreements (the Settlement Agreement) with Bank of America Corporation and certain of its subsidiaries (Bank of America).
Under the terms of the Settlement Agreement, MBIA Corp. will receive a net payment of approximately $1.7 billion, consisting of approximately $1.6 billion in cash and $137 million principal amount of MBIA Inc.'s 5.70% Senior Notes due 2034.
Can MBI Recover After The Recent fall? Find Out Here
James River Coal Company(NASDAQ:JRCC) shares climbed 18.37% to $2.32. The company on May 1 announced that it had net loss of $42.1 million or $1.21 per diluted share for the first quarter of 2013. The 2013 results are compared to net loss of $15.7 million or $.45 per diluted share for the first quarter of 2012. Revenue slumped 36% to $193.3 million. Analysts projected a loss of $1.60 a share on $191 million in revenue.
Additionally, JRCC’s stock had its price target decreased by Deutsche Bank from $2.50 to $2.00 in a research report sent to investors on May 6. The firm currently has a hold rating on the stock.
Can JRCC Continue To Move Higher? Find Out Here
Celsion Corporation (NASDAQ:CLSN) shares climbed 10% to $0.968. The company, on April 23, provided a business update, including the latest findings from its analysis of clinical trial results for ThermoDox®, Celsion's proprietary heat-activated liposomal encapsulation of doxorubicin. Celsion is evaluating ThermoDox® in a Phase III clinical trial for primary liver cancer (the HEAT Study), a Phase II clinical trial for colorectal liver metastasis and a Phase II clinical trial for recurrent chest wall breast cancer.
Additionally, the company announced that it would hold a conference call to discuss first quarter 2013 results at 11:00 a.m. EDT on Thursday, May 9, 2013.
How Should Investors Trade CLSN Now? Find Out Here
Jackpotpennystocks.com has a finger on the pulse of many sectors including renewable energy, oil, pharma, mining, finance, and healthcare. Our in depth research and analysis of NASDAQ, OTCBB, Pink Sheets, and NYSE has yielded considerable gains for our subscribers.
Our to-the-minute reports and alerts coupled with breaking news, analysis, investment strategies, and FREE subscription email services contribute to our role as one of the leading investor relations marketing firms.
The assembled information disseminated by Jackpotpennystocks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Jackpotpennystocks.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)